Stock AFXA CARL ZEISS MEDITEC AG
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Carl Zeiss Meditec AG Deutsche Boerse AG

Equities

AFXA

US14218T1051

Market Closed - Deutsche Boerse AG
Other stock markets
 02:04:20 2024-06-21 am EDT 		5-day change 1st Jan Change
65 EUR -2.99% Intraday chart for Carl Zeiss Meditec AG -20.73% -31.94%
Jun. 19 CARL ZEISS MEDITEC : CZM’s eye attractiveness fades Alphavalue
Jun. 18 CARL ZEISS MEDITEC : CZM’s eye attractiveness fades Alphavalue

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
  • The company benefits from high valuations in earnings multiples.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • The company is not the most generous with respect to shareholders' compensation.
  • For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
  • For the last few months, analysts have been revising downwards their earnings forecast.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
CARL ZEISS MEDITEC AG Stock Carl Zeiss Meditec AG
-31.94% 6.16B -
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+6.37% 216B
B
DANAHER CORPORATION Stock Danaher Corporation
+10.21% 189B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+28.22% 153B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+34.42% 114B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.80% 63.2B
A-
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+19.21% 54.78B
B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+0.13% 48.47B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-4.16% 38.88B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+2.39% 36.14B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. AFX Stock
  4. AFXA Stock
  5. Ratings Carl Zeiss Meditec AG